OnCore Login

Return to Trial Database

QL03-70

Phase II Trial of Olanzapine (Zyprexa) and Palonosetron (Aloxi) for the Prevention of Chemotherapy Induced Nausea and Vomiting

Status

Study Completed

Cancer Type(s)

Quality of Life

Study Contact

Publications

A phase II trial of olanzapine and palonosetron for the prevention of chemotherapy induced nausea and vomiting (CINV)
  • RM Navari, LH Einhorn, PJ Loehrer, SD Passik, J Vinson, J McClean, N Chowhan, N Hanna, C Calley, M Yu
A Phase II Trial of Olanzapine (Zyprexa) and Palonosetron (Aloxi) for the Prevention of Chemotherapy Induced Nausea and Vomiting
  • RM Navari, LH Einhorn, PJ Loehrer, SD Passik, J Vinson, J McClean, N Chowhan, N Hanna, C Calley, M Yu
A Phase II Trial of Olanzapine, Dexamethasone and Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting
  • RM Navari, LH Einhorn, PJ Loehrer Sr., SD Passik, J Vinson, J McClean, N Chowhan, N Hanna, C Johnson

Trial Locations

All sites in which the trial QL03-70 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278